1Spina E, Avenoso A, Scordo Mg, et al. Inhibition of rlsperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevent pharmaco -kinetic drug interaction[J]. J Clin Psychopharmacol, 2002, 22(4): 419.
2Spina E, Avenoso A, Facciola G, et al. Plasma concentrations of risperidone and 9 - hydroxyrisperidone during combined treatment with paroxetine [J].Ther Drug Monit, 2001, 23(3) :223.
3Reeves RR, Mack JE, Beddingfield JJ. Neurotoxic syndrome associated with risperidone and fluvoxamine [ J ]. Ann Pharmacother, 2002, 36 (3): 440.
4Loonen A J, Doorschot CH, Oostelbos MC, et al. Lack of drug interactions between mitazapine and risperidone in psychiatric patients: a pilot study[J]. Eur Neuropsychopharmacol, 1999, 10( 1 ): 51.
5Amchin J, Zarycranski W, Taylor KP, et al. Effect of venlafaxine on the pharmacokinetics of risperidone [ J ]. J Clin Pharmacol, 1999, 39 ( 3 ) : 297.
6Spina E, Avenoso A, Facciola G, et al. Plasma concentration of risperidone and 9 - hydroxyrisperidone: effect of comedication with carbamazepine or valproate[J ]. Ther Drug Monit, 2000, 22(4): 481.
7Mula M, Monaco F. Carbamazepine -risperidone interaction in patients with epilepsy [ J ]. Clin Neuropharmaclo, 2002, 25 (2) : 97.
8Fisman S, Reniers D, Diaz P. Erythromycin interaction with risperidone or clomipramine in an adolescent [ J ]. J Child Adolesc Psychopharmacol,1996, 6(2): 133.
9Steel M, Couturier J. A possible tetracycline - risperidone - sertra line interaction in an adolescent[J]. Can J Clin Pharmacol, 1999,6(1 ): 15.
10Jover F, Cuadrado JM, Andreu L, et al. Reversible coma caused by risper -idoneritonavir interaction[J]. Clin Neuropharmacol, 2002, 25 (5): 251.
